Skip to main content

7 publications

Name Date Type Actions

H1 2021 results

H1 2021 results

29/07/2021 Half Year Report

2021 first half results

2021 Half year results

29/07/2021 Public releases

2020 annual results 2020 sales: €427.5m (up 8.0% as reported)

EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%)
Net income - Group share: €19.2m (4.5% of sales)
Cash flow: €92.2m

01/04/2021 Public releases

First half Results

2012 Half year results

30/08/2012 Half Year Report

2011 ANNUAL RESULTS

SFAF meeting April 4, 2012

05/04/2012 Annual Report

Vétoquinol returns to growth

Lure (France), 29 August 2012 – At its 29 August 2012 meeting, the Vétoquinol S.A. board of directors reviewed the Group results and approved the financial statements for the first six months of 2012.

29/08/2012 Public releases

Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.

08/02/2021 press release excluding results